Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_assertion type Assertion NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_head.
- NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_assertion description "[AH patients showed strong signals compared to CH patients, liver cirrhosis (LC; n = 12; 72% positive) patients, and hepatocellular carcinoma (HCC; n = 21; 19% positive) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_provenance.
- NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_assertion evidence source_evidence_literature NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_provenance.
- NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_assertion SIO_000772 8395442 NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_provenance.
- NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_assertion wasDerivedFrom befree-20140225 NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_provenance.
- NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_assertion wasGeneratedBy ECO_0000203 NP549672.RAfmrSP0o-aJph6IMcNX6p5vjTNoWcBMXuULmmpKGoae0130_provenance.